nccn endometrial cancer genetic testing | Treatment by Cancer Type

Keyword	CPC	PCC	Volume	Score	Length of keyword
nccn endometrial cancer genetic testing	1.2	0.5	8134	91	39
nccn	0.65	0.9	3463	93	4
endometrial	1.48	0.9	8502	17	11
cancer	0.95	0.1	4602	56	6
genetic	1.31	1	6005	8	7
testing	0.69	0.8	6088	48	7

Keyword	CPC	PCC	Volume	Score
endometrial cancer surveillance nccn	1.18	0.5	7114	7
nccn guidelines endometrial cancer	0.37	1	7687	65
endometrial cancer treatment guidelines nccn	0.27	1	4475	54
nccn breast cancer genetic testing	1.54	0.3	5745	68
nccn endometrial cancer staging	1.5	0.1	8997	65
nccn guidelines endometrial carcinoma	0.75	0.1	1407	85
endometrial cancer genetic testing	0.32	0.1	1251	65
nccn cancer genetic testing guidelines	0.44	0.4	2216	92
nccn guidelines endometrial cancer 2022	1.66	0.7	4155	58
nccn genetic testing guidelines breast cancer	0.35	0.7	4234	1
nccn guidelines hereditary cancer testing	0.09	0.8	3342	35
nccn endometrial cancer 2023	1.4	0.3	2071	20
nccn guidelines endometrial cancer 2023	0.43	0.2	958	28
cancer de endometrio nccn	1.91	0.1	8982	39
nccn guidelines genetic testing	1.34	0.2	7504	84
nccn breast cancer genetics	0.82	0.5	5850	8
nccn guidelines uterine cancer	0.96	0.8	4779	34
surveillance for endometrial cancer	0.16	0.2	9022	3
endometrial cancer surveillance guidelines	0.96	1	828	34
nccn colon cancer surveillance	1.59	0.8	3157	17
nccn anal cancer surveillance	1.37	0.2	1776	57
uterine cancer staging nccn	1.67	0.4	7454	14
nccn guidelines breast cancer surveillance	0.62	0.5	6287	74

Search Results related to nccn endometrial cancer genetic testing on Search Engine

Treatment by Cancer Type - NCCN
nccn.org:443

https://www.nccn.org:443/guidelines/category_1

WebGenetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Genetic/Familial High-Risk Assessment: ... -Related Late and Long-Term Effects Survivorship Care for Healthy Living Systemic Mastocytosis Throat Cancer Thyroid Cancer Uterine Cancer …

DA: 21 PA: 2 MOZ Rank: 95 Up or Down: Up

Uterine Neoplasms, Version 1.2018, NCCN Clinical …
jnccn.org:443

https://jnccn.org:443/view/journals/jnccn/16/2/article-p170.xml

WebFeb 1, 2018 · However, hereditary genetic mutations cause endometrial cancer in about 5% of patients, which occurs 10 to 20 years before sporadic cancer. 12 Screening of the … Author: Wui Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, H... Publish Year: 2018

Author: Wui Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, H...
Publish Year: 2018

DA: 75 PA: 80 MOZ Rank: 31 Up or Down: Up

NCCN Guidelines® Insights: Uterine Neoplasms, …
jnccn.org:443

https://jnccn.org:443/view/journals/jnccn/19/8/article-p888.xml

WebAug 1, 2021 · The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment … Author: Nadeem R. Abu-Rustum, Catheryn M. Yashar, Kristin Bradley, Susana M. Campos, Junzo Chino, Hye Sook C... Publish Year: 2021

Author: Nadeem R. Abu-Rustum, Catheryn M. Yashar, Kristin Bradley, Susana M. Campos, Junzo Chino, Hye Sook C...
Publish Year: 2021

DA: 71 PA: 18 MOZ Rank: 65 Up or Down: Up

Detection, Prevention, and Risk Reduction - NCCN
nccn.org:443

https://www.nccn.org:443/guidelines/category_2

WebNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) are posted with the latest update date and version number. Breast Cancer Risk Reduction. Version: 2.2024. …

DA: 23 PA: 69 MOZ Rank: 45 Up or Down: Up

Uterine Neoplasms, Version 1.2023, NCCN Clinical …
jnccn.org:443

https://jnccn.org:443/view/journals/jnccn/21/2/article-p181.xml

WebThe Cancer Genome Atlas (TCGA) study performed an integrated genomic, transcriptomic, and proteomic analysis of 373 endometrial carcinomas including low-grade endometrioid, high-grade …

DA: 29 PA: 81 MOZ Rank: 65 Up or Down: Up

Uterine Neoplasms, Version 1.2023, NCCN Clinical …
nih.gov:443

https://pubmed.ncbi.nlm.nih.gov:443/36791750/

WebStromal or mesenchymal sarcomas are uncommon subtypes accounting for approximately 3% of all uterine cancers. This selection from the NCCN Guidelines for Uterine … genetic testing

genetic testing

DA: 32 PA: 1 MOZ Rank: 27 Up or Down: Up

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in
jnccn.org

https://jnccn.org/view/journals/jnccn/21/2/article-p181.xml

Dr. Himabindu Sreenivasulu

DA: 98 PA: 14 MOZ Rank: 68 Up or Down: Up

NCCN Guidelines® Insights: Uterine Neoplasms, …
nih.gov:443

https://pubmed.ncbi.nlm.nih.gov:443/34416706/

WebAug 1, 2021 · Uterine Neoplasms* / diagnosis. Uterine Neoplasms* / genetics. Uterine Neoplasms* / therapy. The NCCN Guidelines for Uterine Neoplasms provide …

DA: 18 PA: 76 MOZ Rank: 41 Up or Down: Up

Genetic Susceptibility to Endometrial Cancer: Risk …
nih.gov:443

https://www.ncbi.nlm.nih.gov:443/pmc/articles/PMC7565375/

WebAug 25, 2020 · MMR protein loss or high microsatellite instability is present in 23–35% of unselected endometrial cancers. The identification of a pathogenic germline mutation …

DA: 95 PA: 76 MOZ Rank: 32 Up or Down: Up

A clinical guide to hereditary cancer panel testing: …
nih.gov:443

https://www.ncbi.nlm.nih.gov:443/pmc/articles/PMC7000322/

WebAug 13, 2019 · We identified extensive genetic heterogeneity surrounding predisposition to cancer types commonly referred for germline testing (breast, ovarian, colorectal, …

DA: 99 PA: 14 MOZ Rank: 66 Up or Down: Up

Endometrial cancer: molecular classification and future …
bmj.com:443

https://bmjmedicine.bmj.com:443/content/bmjmed/1/1/e000152.full.pdf

WebThe Cancer Genome Atlas was the first to evaluate a large number of cancers through whole genome sequencing, including endometrial cancer.12 The Cancer Genome Atlas …

DA: 5 PA: 83 MOZ Rank: 24 Up or Down: Up